Featured news in The Life Sciences Report



Cesca Therapeutics Inc. (KOOL:NASDAQ)
ThermoGenesis Receives Health Canada Approval of its Next-Generation AXP® II System for Cord Blood Processing (6/18/2019)

view
 


DURECT Corp. (DRRX:NASDAQ)
DURECT Announces Completion of the 90 mg Severe Cohort and Dose Escalation Committee Approval to Commence 150 mg Dosing in Patients with Severe Alcoholic Hepatitis (AH) in its Ongoing DUR-928 Phase 2a AH Trial (6/18/2019)

view
 


Celgene Corp. (CELG:NASDAQ)
Novartis (NVS) Announces Promising Data on Tasigna & Hyrimoz (6/17/2019)

view
 

Celgene Corp. (CELG:NASDAQ)
Celgene (CELG) Hits 52-Week High, Can the Run Continue? (6/18/2019)

view
 


Amarantus BioScience Holdings Inc. (AMBS:OTCQB)
Amarantus Announces Positive Pre-Clinical Data for MANF in Wolfram Syndrome Presented at the 79th Annual Scientific Sessions of the American Diabetes Association (6/18/2019)

view
 


Mesoblast Ltd. (MESO:NASDAQ; MSB:ASX)
High Economic Burden in Children With Steroid Refractory Acute Graft Versus Host Disease (6/18/2019)

view
 


Sproutly Canada Inc. (SPR:CSE; SRUTF:OTCQB)
Sproutly Announces First Commercial Sale of Cannabis Flower (6/17/2019)

view
 


Celgene Corp. (CELG:NASDAQ)
Regeneron (REGN) Presents Positive Data on Lymphoma Candidate (6/17/2019)

view
 


MiMedx Group Inc. (MDXG:NASDAQ)
MiMedx Shareholders Overwhelmingly Support Election of All Three of MiMedx's Highly Qualified Director Nominees (6/17/2019)

view
 


Amarantus BioScience Holdings Inc. (AMBS:OTCQB)
Todos Medical CEO Presented Corporate Update And Roadmap at The LD Micro Conference (6/17/2019)

view